Didier Rouy

4.2k total citations · 1 hit paper
35 papers, 2.0k citations indexed

About

Didier Rouy is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Didier Rouy has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Surgery and 9 papers in Hematology. Recurrent topics in Didier Rouy's work include Mesenchymal stem cell research (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Virus-based gene therapy research (6 papers). Didier Rouy is often cited by papers focused on Mesenchymal stem cell research (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Virus-based gene therapy research (6 papers). Didier Rouy collaborates with scholars based in United States, France and Luxembourg. Didier Rouy's co-authors include Michel F. Bureau, Daniel Scherman, Jean‐Michel Caillaud, Julie Gehl, Bertrand Schwartz, Ravi Rangara, Lluis M. Mir, P. Delaère, Didier Branellec and Eduardo Anglés‐Cano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Didier Rouy

34 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1999 749 citations Didier Rouy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Didier Rouy United States	19	889	592	471	306	299	35	2.0k
L Weir United States	12	1.2k 1.4×	344 0.6×	234 0.5×	95 0.3×	449 1.5×	14	2.0k
Boris Minev United States	26	824 0.9×	319 0.5×	138 0.3×	111 0.4×	238 0.8×	61	2.1k
Hideyo Hirai Japan	33	1.4k 1.6×	168 0.3×	104 0.2×	80 0.3×	301 1.0×	105	3.4k
Daekwan Seo South Korea	30	1.4k 1.6×	536 0.9×	54 0.1×	135 0.4×	208 0.7×	46	2.6k
Richard M. Leimgruber United States	17	1.4k 1.6×	190 0.3×	88 0.2×	55 0.2×	154 0.5×	27	2.0k
Anita J. Merritt United Kingdom	18	1.3k 1.5×	170 0.3×	244 0.5×	27 0.1×	179 0.6×	23	2.3k
Yuji Kashiwakura Japan	24	954 1.1×	173 0.3×	62 0.1×	44 0.1×	502 1.7×	68	2.0k
Dong Gao China	27	1.7k 1.9×	313 0.5×	99 0.2×	476 1.6×	160 0.5×	68	3.3k
Brigitte Hantusch Austria	15	759 0.9×	304 0.5×	68 0.1×	262 0.9×	55 0.2×	22	1.8k
Yoko Oei United States	12	1.4k 1.5×	109 0.2×	165 0.4×	353 1.2×	170 0.6×	17	3.6k

Countries citing papers authored by Didier Rouy

Since Specialization

Citations

This map shows the geographic impact of Didier Rouy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Rouy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Rouy more than expected).

Fields of papers citing papers by Didier Rouy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Rouy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Rouy. The network helps show where Didier Rouy may publish in the future.

Co-authorship network of co-authors of Didier Rouy

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Rouy. A scholar is included among the top collaborators of Didier Rouy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Rouy. Didier Rouy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harmatz, Paul, Carlos E. Prada, Barbara K. Burton, et al.. (2022). First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B. Molecular Therapy. 30(12). 3587–3600. 50 indexed citations

Walters, Mark C., Angela R. Smith, Gary J. Schiller, et al.. (2021). Updated Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent Beta Thalassemia. Blood. 138(Supplement 1). 3974–3974. 15 indexed citations

Visweshwar, Nathan, Thomas J. Harrington, Andrew D. Leavitt, et al.. (2021). Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults with Severe Hemophilia a. Blood. 138(Supplement 1). 564–564. 16 indexed citations

Leavitt, Andrew D., Barbara A. Konkle, Kimo C. Stine, et al.. (2020). Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a. Blood. 136(Supplement 1). 12–12. 21 indexed citations

Penn, Marc S., Farrell O. Mendelsohn, Gary L. Schaer, et al.. (2012). Re-Establishment of SDF-1 Expression Through Non-Viral Gene Therapy Improves Clinical Parameters Through 12 Months in Patients With Ischemic Class III Heart Failure. Journal of Cardiac Failure. 18(8). S59–S60. 1 indexed citations

Williams, Adam, Barry Trachtenberg, Darcy L. Velazquez, et al.. (2011). PRELIMINARY RESULTS FROM THE TRANSENDOCARDIAL INJECTIONS OF AUTOLOGOUS WHOLE BONE MARROW AND MESENCHYMAL STEM CELLS IN ISCHEMIC HEART FAILURE (TAC-HFT) TRIAL. Journal of the American College of Cardiology. 57(14). E242–E242. 1 indexed citations

Fuente, Luís de la, et al.. (2011). Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study). EuroIntervention. 7(7). 805–812. 11 indexed citations

Trachtenberg, Barry, Darcy L. Velazquez, Adam Williams, et al.. (2011). Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. American Heart Journal. 161(3). 487–493. 107 indexed citations

Rouy, Didier, Frédéric Lebrun, Guy Berchem, et al.. (2008). Cell therapy for severe chronic heart failure: the Luxembourg experience.. PubMed. 18(1 Suppl). S27–31. 5 indexed citations

10.

Lebrun, Frédéric, Guy Berchem, Charles Delagardelle, et al.. (2006). Improvement of Exercise-Induced Cardiac Deformation After Cell Therapy for Severe Chronic Ischemic Heart Failure. Journal of Cardiac Failure. 12(2). 108–113. 4 indexed citations

11.

Connolly, Eileen P., et al.. (2006). Inhibition of Cap-initiation complexes linked to a novel mechanism of eIF4G depletion in acute myocardial ischemia. Cell Death and Differentiation. 13(9). 1586–1594. 8 indexed citations

12.

Rouy, Didier, et al.. (2004). Plasma storage at −80 °C does not protect matrix metalloproteinase-9 from degradation. Analytical Biochemistry. 338(2). 294–298. 79 indexed citations

13.

Lambert, Gilles, Berlinda Vanloo, Didier Rouy, et al.. (1998). The C‐terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high‐density lipoproteins. European Journal of Biochemistry. 253(1). 328–338. 22 indexed citations

14.

Rouy, Didier, Nicolas Duverger, Florence Emmanuel, et al.. (1998). Apolipoprotein(a) Yeast Artificial Chromosome Transgenic Rabbits. Journal of Biological Chemistry. 273(2). 1247–1251. 37 indexed citations

15.

Lestavel, Sophie, Stéphane Nion, Didier Rouy, et al.. (1997). HDL3 binds to glycosylphosphatidylinositol-anchored proteins to activate signalling pathways. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1358(1). 103–112. 8 indexed citations

16.

Benetollo, Claire, Gilles Lambert, Berlinda Vanloo, et al.. (1996). Lipid‐Binding Properties of Synthetic Peptide Fragments of Human Apolipoprotein A‐II. European Journal of Biochemistry. 242(3). 657–664. 7 indexed citations

17.

Hughes, Steven D., Didier Rouy, Naveenan Navaratnam, James Scott, & Edward M. Rubin. (1996). Gene Transfer of Cytidine Deaminase apoBEC-1 Lowers Lipoprotein(a) in Transgenic Mice and Induces Apolipoprotein B Editing in Rabbits. Human Gene Therapy. 7(1). 39–49. 37 indexed citations

18.

Anglés‐Cano, Eduardo, et al.. (1994). Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator. Chemistry and Physics of Lipids. 67-68. 369–380. 35 indexed citations

19.

Rouy, Didier, Marlys L. Koschinsky, V. Fleury, John Chapman, & Eduardo Anglés‐Cano. (1992). Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry. 31(27). 6333–6339. 80 indexed citations

20.

Anglés‐Cano, Eduardo, Didier Rouy, & Henri Roger Lijnen. (1992). Plasminogen binding by α2-antiplasmin and histidine-rich glycoprotein does not inhibit plasmiogen activation at the surface of fibrin. Biochimica et Biophysica Acta (BBA) - General Subjects. 1156(1). 34–42. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact